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June Supplement 201072S AbstractsObjectives: We have previously shown that periadven-
titial delivery of nitric oxide (NO) after arterial injury
prevents the development of neointimal hyperplasia; how-
ever, the durability of NO-based therapies is unknown. We
hypothesize that the effect of NO is durable and due to
alteration of cell populations within the arterial wall.
Methods: The carotid artery balloon injury model was
performed on Sprague Dawley rats. Treatment groups in-
cluded Injury (I) or IPROLI/NO (20mg). Arteries were
harvested at 2 and 8 wks. Neointimal hyperplasia was
quantified morphometrically. Van Gieson stain assessed
collagen content. Immunohistochemical staining for
SMC actin and desmin assessed smooth muscle cell
(SMC) and fibroblast phenotype.
Results: NO reduced intimal area (90 and 95%, p 
0.001), medial area (46 and 47%, p 0.001), and intima/
media area ratio (82 and 69%, p  0.001) at 2 and 8 wks,
respectively, with no statistical difference between time
points. Qualitatively, NO decreased collagen content com-
pared to I alone. NO reduced total cell number in the
arterial wall at 2 and 8 wks (51 and 42%, resp., p  0.001)
by decreasing cell number in the intima (85%, p  0.001)
andmedia (93%, p 0.001), but not the adventitia. In fact,
adventitial cell count was greater in NO-treated arteries
compared to I alone (39% and 54% at 2 and 8 wks, p 
0.001). At 8 wks, an increase in cell number was observed
in the adventitia (9%) and media (85%) in the NO-treated
arteries compared to the I alone arteries, which was stable.
Lastly, SMC markers SMC actin and desmin were de-
creased at 2 and 8 wks in NO-treated arteries compared to
I alone (52 and 70%, resp., p0.009), but this effect was
limited to the intima and media.
Conclusions: Periadventitial delivery of NO results in
durable inhibition of neointimal hyperplasia. Our data sug-
gest that NO reduces collagen content, inhibits repopula-
tion of the media, and inhibits migration of adventitial cells
to the intima and media after arterial injury.
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Toll-like Receptors 2 and 4, but Not RAGE Deficiency
Results in Greater Muscle Necrosis 2 Weeks After
Hind-limb Ischemia: Implications for Muscle Recovery
After Ischemic Injury
Ulka Sachdev, Xiangdong Cui, Tian Wang, Edith Tzeng.
Division of Vascular Surger, NorthwesternUniversity, Chi-
cago, IL
Objectives: Innate immunity is the first line of defense
against invading pathogens through receptors such as
TLR2 and TLR4. These receptors also mediate responses
to tissue injury through endogenous danger signals. We
have shown that HMGB1, a danger signal, is released byhypoxic cells and promotes angiogenesis in vitro. Anti-
HMGB1 antibody increases muscle necrosis in murine
hind-limb ischemia but did not change endothelial density,
supporting a role for HMGB1 and innate immunity in
skeletal muscle recovery following ischemia. In this study,
we examined the roles of the HMGB1 receptors TLR2,
TLR4 and RAGE in mediating this protection.
Methods: 10-12 wk old mice genetically deficient for
TLR4 (C3H/HeJ, control HeOuJ; N  4), TLR2 (N 
3), or RAGE (N 4; control C57B/6, N 4) underwent
right femoral artery ligation. At 2wks, calf muscles were
fixed, sectioned, and stained with H&E to quantify muscle
necrosis (% area) and vWF for endothelial density. Statisti-
cal significance was determined by ANOVA.
Results: TLR4 mutant mice developed greater muscle
necrosis following hind-limb ischemia than control HeOuJ
mice (16.4% 4.6 vs 4.6 2.1; p 0.04). Muscle necrosis
was also markedly increased in TLR2 KO (23.5  17.3;
P-0.04) while no necrosis was detected in the C57B/6
controls. RAGE KO mice also showed little necrosis. In
contrast, the C57B/6 and RAGE KO mice exhibited sig-
nificant muscle regeneration in the ischemic hind-limb.
Endothelial density was similar between the knockout and
control mice.
Conclusions: The absence of TLR2 and TLR4 signal-
ing is associated with increased skeletal muscle necrosis
following ischemia and suggests that these receptors are
necessary for muscle protection. In contrast, RAGE signal-
ing is not involved. The protection offered by TLR2 and
TLR4 did not involve endothelial proliferation but may
involve regenerative processes. These data suggest that
TLRs may be critical in tissue recovery from ischemia
independent of angiogenesis.
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A Specific Inhibitor of IGF-1 Receptor - Picropodo-
phyllin Can Suppress Atheroma Progression and Has a
Stabilizing Effect on Atherosclerotic Lesions in ApoE
Deficient Mice
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Objectives: IGF-1 has been shown to play an impor-
tant role in proliferation, migration, and inhibition of apo-
ptosis in SMCs during restenosis development. In our
previous studies we showed that specific inhibition of IGF-
1receptor (IGF-1R) by the cyclolignan picropodophyllin
(PPP) inhibits SMC replication, and subsequently attenu-
ates intimal hyperplasia after balloon injury of rat carotid
arteries. SMC proliferation and migration contribute to
healing processes in atherosclerotic plaques and the IGF-1
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the same time, the mitogenic activity of IGF-1 can promote
development of intimal hyperplasia and restenosis. Aim: To
evaluate the possible effect of IGF-1R inhibition on athero-
sclerosis progression.
Methods: 16 ApoE-/- mice were treated orally with
PPP 3.2 mg/day between 11 and 25 or 33 weeks of age.
Control group consisted of 16 animals given normal chow
diet. Atherosclerosis burden was evaluated by en face Sudan
IV staining of aortas. At the same time structure of the
atherosclerotic plaques was assessed on the crossections of
brachiocephalic trunk.
Results: Animals treated with PPP had decreased
plaque area in the aorta; this effect was stronger at 25 weeks
of age (5.2% of the aortic wall in control group and 2.2% in
PPP group) and less pronounced at 33 weeks of age (9.8%
and 11.3% respectively). Size of the lesions in brachioce-
phalic trunk was also reduced by PPP from 48.2% of cross
lumen area in control group to 27.0% in PPP group at 25
weeks and from 61.4% to 46.0% at 33 weeks respectively.
Furthermore, PPP treated lesions showed more a promi-
nent fibrous cap, had less amounts of cholesterol and a
higher cellularity.
Conclusions: Specific inhibition of IGF-1R suppressed
progression of atheroma in ApoE deficient animals. Fur-
thermore treatment with PPP has a stabilizing effect on the
advanced lesions in brachiocephalic trunk. Further studies
are required to investigate mechanisms of the described
effects.
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Cytostatic Gene Therapy: RNAi-Mediated Survivin
Knockdown Induces Cell Cycle Arrest, Polyploidy, and
Reduced Migration of Vascular Smooth Muscle Cells
(VS MC)
Christoph S. Nabzdyk, Hope Lancero, Khanh P. Nguyen,
Sherveen Salek, Michael S. Conte. Division of Vascular
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Objectives: Survivin (SVV) has been implicated in the
development of neointimal hyperplasia. We investigated
the effects of RNA-interference (RNAi) mediated SVV
knockdown on VS MC phenotype.
Methods: SVV knockdown was achieved by either
siRNA or lentiviral transduction of shRNA in primary
cultured VS MC from human saphenous vein. Prolifera-
tion, cell cycle kinetics, apoptosis and migration were
assessed.
Results: RNAi reduced SVV gene expression by qPCR
(75%, p  0.01), without loss of cell viability. RNAi treat-
ment increased p53 levels, whereas total cellular SVV levelswere variable. Subcellular fractionation revealed the major-
ity of SVV protein in VS MC is mitochondrial. SVV RNAi
treatment blocked proliferation in response to serum and
PDGF-AB (p 0.05, Fig 1). Cell cycle analysis revealed no
evidence of G1/S block, but an increased G2/M fraction
(27% SVV siRNA vs 17% control siRNA, p 0.05) consis-
tent with a mitotic defect. In a Transwell assay, SVV knock-
down reduced migration to PDGF-AB (74% vs controls, p
 0.01), and actin-phalloidin staining revealed disorga-
nized actin filaments and polygonal cell shape. Apoptosis
was not induced by SVV RNAi, and sensitivity to apoptotic
agonists (staurosporine, cytokines) was unchanged.
Conclusions: RNAi targeting SVV in VS MC leads to
cell cycle arrest at G2/M and impaired chemotaxis. Regu-
lation of mitosis and apoptosis in VSMC appears to involve
differentially regulated pools of SVV. Treatment of VS MC
with SVV RNAi might limit the response to vascular injury
without destabilizing the vessel wall.
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Surgical Restoration of Flow Following Prolonged
Ischemia Inhibits Neuromuscular Recovery in a Por-
cine (Sus Scrofa) Model of Extremity Vascular Injury
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tonio, TX; 3The Uniformed Services University of the
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Objectives: Despite advances in revascularization fol-
lowing extremity injury the relationship between time to
restoration of flow and functional limb salvage is unknown.
The objectives of this study are to describe a large animal
model of hind limb ischemia/reperfusion and to define an
extremity ischemic threshold from clinically relevant mea-
sures of neuromuscular recovery
Methods: Sus scrofa swine (N 38; weight [kg] SD
87 kg  6.2) were randomized to iliac artery injury and
occlusion for 0 (Control), 1 (1HR), 3 (3HR), or 6 (6HR)
hours followed by vessel repair and 14 days of recovery.
Two groups underwent iliac artery division with no resto-
ration of flow (Ligation), or exposure without intervention
(Sham). A composite physiologic measure of recovery
(PMR) was generated to assess group differences across
14-days of survival. PMR included hind limb function
(Tarlov score) and electrophysiologic measures (com-
poundmuscle action potential (CMAP) amplitude, sensory
